P1.04: Defining the Genetic Architecture of Lung Cancer Etiology: Track: Prevention, Early Detection, Epidemiology and Tobacco Control.
approach; and, (4) identified two TM (NSE and ProGRP) that differentiate the risk of NSCLC from that of SCLC. Conclusion: The combined assessment of a panel of six serum TM is a more accurate marker for LC presence that these same TM considered individually. The potential of these TM in the diagnostic and screening settings deserves further research Molina R, Marrades RM, Auge JM, Escudero JM, Vinolas N, Reguart N, Ramirez J, Filella X, Molins L, Agusti A.Am J Respir Crit Care Med. 2016 Feb 15;193(4):427 37.
Journal of thoracic oncology official publication of the International Association for the Study of Lung Cancer